Fundraising FoxFastinov
2 known investors
Find your way into Fastinov
Sign up to see every warm intro you have to Fastinov
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Fastinov team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
FASTinov develops phenotypic Antimicrobial Susceptibility Testing (AST) kits that deliver results within 2 hours directly from blood cultures, covering gram negative and gram positive panels. Its CE-marked in vitro diagnostic products serve clinical laboratories in the European Union.
Investors · 2
Related companies · 5
BDBD is a global medical technology company developing devices, systems, and solutions for medication administration, diagnostics, connected care, biopharmaceutical manufacturing, and interventional procedures. The company serves healthcare providers, laboratories, and biopharmaceutical manufacturers across diagnostics, drug delivery, surgical care, and patient monitoring.
BioMérieuxbioMérieux develops in vitro diagnostic solutions for clinical laboratories and healthcare professionals, covering areas such as antimicrobial stewardship, sepsis, and infectious disease detection. It also provides diagnostics for food safety and quality and pharmaceutical quality control.
Affinity BiosensorsAffinityBio develops LifeScale, a diagnostic system that uses population-profiling technology to identify Gram-negative bacteria in positive blood cultures and perform antibiotic susceptibility testing in roughly 4.5 hours. The system automates sample inoculation, incubation, reading, and reporting for clinical microbiology labs.
iFASTiFAST Diagnostics develops rapid antimicrobial susceptibility testing (AST) technology that delivers susceptibility test results in under 3 hours, significantly faster than the standard 40-hour process. The company serves clinical laboratories and hospitals to help combat antimicrobial resistance.
OupOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.
Companies working in the same space as Fastinov.
Frequently asked questions
- What does Fastinov do?
- FASTinov develops phenotypic Antimicrobial Susceptibility Testing (AST) kits that deliver results within 2 hours directly from blood cultures, covering gram negative and gram positive panels. Its CE-marked in vitro diagnostic products serve clinical laboratories in the European Union.
- Who are Fastinov's investors?
- Fastinov's investors include Armilar Venture Partners, Bynd Venture Capital.